299 related articles for article (PubMed ID: 14586892)
1. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
Gane E
Liver Transpl; 2003 Nov; 9(11):S28-34. PubMed ID: 14586892
[TBL] [Abstract][Full Text] [Related]
2. The natural history of recurrent hepatitis C and what influences this.
Gane EJ
Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
[TBL] [Abstract][Full Text] [Related]
3. Natural history of recurrent hepatitis C.
Berenguer M
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S14-8. PubMed ID: 12362293
[TBL] [Abstract][Full Text] [Related]
4. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
[TBL] [Abstract][Full Text] [Related]
6. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression.
Maluf DG; Archer KJ; Villamil F; Stravitz RT; Mas V
Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):445-58. PubMed ID: 20678018
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
9. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis.
Berenguer M; Prieto M; Palau A; Rayón JM; Carrasco D; Juan FS; López-Labrador FX; Moreno R; Mir J; Berenguer J
Liver Transpl; 2003 Mar; 9(3):228-35. PubMed ID: 12619018
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
11. Natural history of hepatitis C and outcomes following liver transplantation.
Rodriguez-Luna H; Vargas HE
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):51-9. PubMed ID: 15719006
[TBL] [Abstract][Full Text] [Related]
12. Management of recurrence of hepatitis C infection following liver transplantation.
Charlton M
Minerva Chir; 2003 Oct; 58(5):717-24. PubMed ID: 14603150
[TBL] [Abstract][Full Text] [Related]
13. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
14. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation.
Berenguer M; Prieto M; Rayón JM; Mora J; Pastor M; Ortiz V; Carrasco D; San Juan F; Burgueño MD; Mir J; Berenguer J
Hepatology; 2000 Oct; 32(4 Pt 1):852-8. PubMed ID: 11003634
[TBL] [Abstract][Full Text] [Related]
15. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
[TBL] [Abstract][Full Text] [Related]
16. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States.
Russo MW; Galanko J; Beavers K; Fried MW; Shrestha R
Liver Transpl; 2004 Mar; 10(3):340-6. PubMed ID: 15004758
[TBL] [Abstract][Full Text] [Related]
17. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatitis C virus infection in the setting of liver transplantation.
Rodriguez-Luna H; Vargas HE
Liver Transpl; 2005 May; 11(5):479-89. PubMed ID: 15838917
[TBL] [Abstract][Full Text] [Related]
19. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
20. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
